Abstract

Cancer cells exhibit properties of cells in a less differentiated state than the adjacent normal cells in the tissue. We explored whether cancer cells can be converted to a differentiated normal-like state by restoring the gene regulatory network (GRN) of normal cells. Here, we report that colorectal cancer cells exhibit a range of developmental states from embryonic and intestinal stem-like cells to differentiated normal-like cells. To identify the transcription factors (TF) that commit stem-like colorectal cancer cells into a differentiated normal-like state, we reconstructed GRNs of normal colon mucosa and identified core TFs (CDX2, ELF3, HNF4G, PPARG, and VDR) that govern the cellular state. We further found that SET Domain Bifurcated 1 (SETDB1), a histone H3 lysine 9-specific methyltransferase, hinders the function of the identified TFs. SETDB1 depletion effectively converts stem-like colorectal cancer cells into postmitotic cells and restores normal morphology in patient-derived colorectal cancer organoids. RNA-sequencing analyses revealed that SETDB1 depletion recapitulates global gene expression profiles of normal differentiated cells by restoring the transcriptional activity of core TFs on their target genes. IMPLICATIONS: Our study provides insights into the molecular regulatory mechanism underlying the developmental hierarchy of colorectal cancer and suggests that induction of a postmitotic state may be a therapeutic alternative to destruction of cancer cells.

Highlights

  • Dysregulation of tissue-specific gene expression programs is a hallmark of cancer [1]

  • We found a significant correlation between the gene set enrichment score for colon-specific genes and tumor size and prognosis of patients with colorectal cancer (Supplementary Fig. S1B and S1C), suggesting that loss of this profile is clinically relevant and may produce histopathologic features of poorly differentiated cancer [37]

  • We found that, compared with the other stem/progenitor gene sets, gene sets associated with intestinal stem cell (ISC) and embryonic stem cell (ESC) are significantly enriched in colorectal cancer (Fig. 1B and C; Supplementary Fig. S2B and S2C), suggesting that these two stem/progenitor expression programs may predominantly drive colorectal cancer– associated dedifferentiation

Read more

Summary

Introduction

Dysregulation of tissue-specific gene expression programs is a hallmark of cancer [1]. A study of cancer initiation revealed that normal differentiated cells with oncogenic mutations remain in a nonmalignant state until they undergo cellular reprogramming into a stem/progenitor state [5]. This suggests that differentiated cells have an inherent resistance mechanism against malignant transformation and indicates that cellular reprogramming is indispensable for malignancy. Cellular differentiation is impeded through processes involving both oncogenic mutations and microenvironmental alterations [9, 10] This cancer provides a model for exploring whether the malignant cells could be converted to normal-like cells

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.